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Conclusion: 1) SRBD was observed in about 1/3 of pts with advanced CHF. 2/3 had a
central form of SRBD. 2) CRT significantly improves AHI and noctural minimal oxygen
saturation in pts with CHF and "CRT on".
11:30 a.m.
879-5 Mechanical Activation Mapping With Strain Imaging: A 
New Approach to Localize Ventricular Lead Placement 
After Cardiac Resynchronization Therapy
Hideaki Kanzaki, Raveen Bazaz, David Schwartzman, Kaoru Dohi, John Gorcsan, III, 
University of Pittsburgh, Pittsburgh, PA
Background: Cardiac resynchronization therapy (CRT) can be beneficial for patients
with heart failure (HF) and left bundle branch block (LBBB). Left ventricular (LV) leads for
CRT are being placed in variable epicardial locations.
Methods: To test the hypothesis that a new mechanical activation mapping method using
echocardiographic strain imaging can localize LV lead placement after CRT, 24 HF
patients with LBBB (EF 24 ± 5%, QRS 164 ± 29 ms) were studied at baseline and the
day after CRT. Strain imaging cineloops were acquired (Vivid 5 or 7, GE Vingmed) from 3
routine apical views: 4-chamber, 2-chamber, and long-axis. The activation maps were
constructed with time-to-peak systolic strain at basal and mid LV walls from each apical
view (12 sites).
Results: At baseline, the earliest mechanical activation occurred at septal sites in 18
(75%), and propagated latest to basal lateral or posterior sites in 19 (79%). After CRT,
the earliest activation site appeared at mid septal-inferior and free wall sites, presumably
from right ventricular apical and LV free wall pacing. The site of LV lead placement (lat-
eral 10, posterolateral 9, anterior 3, anterolateral 1, posterior 1) was identified by the
mapping with the shortest time-to-peak strain in accurate or contiguous LV anatomical
site in 88% (Kappa value 0.88).
Conclusion: Echocardiographic strain mapping revealed changes in the mechanical
activation sequence after CRT and successfully localized LV lead position, which has
promise for clinical utility.
11:45 a.m.
879-6 Left Ventricular Pre-Excitation Is Superior to Right 
Ventricular Pre-Excitation in Sequential Biventricular 
Pacing for Heart Failure
Ilan Hay, Vojta Melenovsky, Barry J. Fetics, Joshua Hare, Daniel Judge, Andrew Kramer, 
Craig Reister, Joe Pastore, Rick Conville, David A. Kass, Ronald Berger, Johns Hopkins 
Medical Institution, Baltimore, MD, Guidant Co., St. Paul, MN
Cardiac resynchronization (CRT) is commonly provided with simultaneous bi-ventricular
pacing; however, sequential Bi-V pacing may be superior. Prior data suggests that overly
premature LV or RV stimulation similarly reduces the effectiveness of CRT. We tested this
hypothesis in nine patients with cardiac failure (EF<30%) and atrial fibrillation. Patients
with marked bradycardia or following AV node ablation were studied to eliminate con-
founding effects of native AV conduction. Bi-V pacing employed an RV-apical and LV-pos-
tero-lateral lead, with RV-LV timing delay varied between -120 msec (RV early) to +120
msec (LV early). In addition, we compared RV only to LV only and Bi-V pacing modes.
Ventricular and aortic pressure data were measured for one minute with each pacing
mode (Table)
Preexcitation of the LV was superior to RV for each time interval tested. Marked pre-exci-
tation of the LV was significantly better than with RV (14.8 ± 2.5% rise in dp/dtmax RV vs
LV, p<0.05). Optimal results were at or near simultaneous activation. Importantly, 120
msec LV pre-excitation was very similar to LV only pacing (14.4 ±2.7 %, better than RV
only), but not as good as Bi-V (21.4 ± 0.76 % over RV, p<0.05). Diastolic function (dp/
dtmin) was also better with synchronized Bi-V pacing and declined with increasing RV-LV
delay intervals for both pre-excitation sequences. We conclude that LV pre-excitation is
superior to RV pre-excitation but offers no advantage over Bi-V pacing in patients without
any supraventricular conduction.
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890-1 Does a Narrow QRS Identify a Low-Risk Subgroup of 
Patients With Ischemic Heart Disease? Results of 
Electrophysiology Testing and T Wave Alternans 
Testing in a "MADIT-2" Population
Kenneth M. Stein, Sei Iwai, Suneet Mittal, Steven M. Markowitz, Ravi K. Yarlagadda, 
Bindi K. Shah, Amit B. Guttigoli, Bruce B. Lerman, Cornell University Medical Center, 
New York, NY
Background: Retrospective analysis of the MADIT-2 database has suggested that the
population with a narrow QRS complex derives less benefit from ICD implantation than
the population with a wide QRS complex. We sought to determine whether the results of
EP-testing (EPS) and T wave alternans testing (TWA) in a population with severe left
ventricular dysfunction and prior myocardial infarction were consistent with this hypothe-
sis.
Methods: We prospectively evaluated 67 patients (53 men, mean age 68±9 yrs) who
were referred for EPS for risk stratification (n=59) or due to a history of syncope or pre-
syncope (n=8). All patients had documented coronary artery disease and a prior myocar-
dial infarction and all had an LVEF < 30% (mean: 25±5%). All pts underwent TWA testing
during rapid atrial pacing (550 msec) with the Cambridge Heart CH2000 system or
HearTwave system at the time of EPS. TWA was interpreted using standard criteria by
two physicians blinded to the results of EPS. The EPS protocol used programmed stimu-
lation at two ventricular sites with up to triple extrastimuli with and without isoproterenol
or dobutamine. Positive EPS was defined as the induction of sustained monomorphic
ventricular tachycardia with up to triple ventricular extrastimuli. A wide QRS was defined
as a QRS duration > 120 msec.
Results: Among the 31 patients with a wide QRS, 65% had positive EP studies vs. 67%
among the 36 patients with a narrow QRS (p=NS). Among patients with a wide QRS 58%
had a positive TWA test vs. 47% with a narrow QRS (p=NS). Excluding patients with
indeterminate TWA tests the positivity rates were 72% and 59% respectively (p=NS). In
fully 90% of wide QRS patients and 81% of narrow QRS patients at least one of the 2
tests (EPS, TWA) was positive (p=NS).
Conclusion: The likelihood of a positive electrophysiologic study and/or TWA test is
remarkably high in a population with ischemic cardiomyopathy and LVEF < 30%, irre-
spective of whether the baseline QRS is wide or narrow. These data do not support the
concept that a narrow QRS identifies a low-risk subpopulation of "MADIT-2"-type
patients.
10:45 a.m.
890-2 Initial Results From the Substrate Mapping and Ablation 
in Sinus Rhythm to Halt Ventricular Tachycardia Trial 
(SMASH VT)
Vivek Y. Reddy, Allison W. Richardson, Petr Neuzil, Krit Jongnarangsin, Stepan Kralovec, 
Lucie Sediva, Milos Taborsky, Matt Reynolds, Mark E. Josephson, Beth Israel-
Deaconess Medical Center, Boston, MA, Na Homolce Hospital, Prague, Czech Republic
Background: In post-MI patients, implantable cardioverter-defibrillators (ICDs) are effec-
tive in terminating ventricular tachycardia (VT) and fibrillation (VF). However, ICD shocks
are painful and do not prevent syncope, and antiarrhythmic drugs (AAD) are often
required. Substrate based catheter ablation has been shown to decrease events in
patients who have received multiple ICD shocks. In this multicenter prospective random-
ized controlled trial, we examined the role of substrate ablation in the primary prevention
of appropriate ICD shocks in high-risk post-MI patients.
←  RV  Pre-Excitation  Interval   LV  Pre-excitation  interval  →
Mean ± S.D RV 
only
80
msec
40
msec
Simul
taneous
40
msec
80
msec 
120
msec
LV
dp/dt max (mmHg/sec)
791 ±
85 *
824±
73 *
885±
107 *
983 ±
138
983 ±
126
961±
117
906±
100*
Arterial
Pulse Pressure 
(mmHg)
34 ±
8.2*
35.7 ±
8.8*
36.5 ±
8.9*
38.6±
9.5
36.8 ±
9.6
37 ±
9.6
34.4 ±
9.6*
Arterial
Mean Pressure 
(mmHg)
80.1 ±
13.5*
81.9 ±
12.9*
82.5±
12.7
84.9 ±
13
83.7 ±
12.6
82.6±
11
80.7±
11.2 *
LV
dp/dt min(mmHg/sec)
-804±
201*
-862±
200*
-891±
206 *
-937±
189
-914±
166
-882±
160*
-852±
171*
* P < 0.05 ( Repetitive ANOVA with Tukey Correction for post hoc Comparisons) 
Compared with Simultaneous Pacing.
